Daniel D. Shoemaker, Chief Scientific Officer at FATE THERAPEUTICS INC (FATE), sold 25,000 shares at $16.94 ($424K) on 2019-03-28, disclosed to the SEC on 2019-03-29.
Open-market sale of $424k FATE by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.94 | 12,500 | $212K | 50.0% |
| 2 | $16.94 | 12,500 | $212K | 50.0% |
| Total | $16.94 avg | 25,000 | $424K | 100% |
| Filing → |
| FATE | SELL | 2020-11-16 | $2.6M | — | Filing → |
| FATE | SELL | 2020-09-16 | $1.8M | — | Filing → |
| FATE | SELL | 2020-01-10 | $118K | — | Filing → |